APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cobamamide for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cobamamide for Injection Industry Growth and Trends Forecast to 2032

Report ID 17397912012 January 202695 pages

Choose your research edition.

Industry ResearchCobamamide for Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cobamamide for Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Cobamamide for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cobamamide for Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cobamamide for Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Cobamamide for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cobamamide for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cobamamide for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cobamamide for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cobamamide for Injection include Chongqing Yaoyou Pharmaceutical, Jiuquan Dadeli pharmaceutical, Jiangsu Jiuxu Pharmaceutical, North China Pharmaceutical Group, Hebei Zhitong Biopharmaceutical, Hainan Star Pharmaceutical and Haerbin Medisan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cobamamide for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cobamamide for Injection market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cobamamide for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cobamamide for Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cobamamide for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cobamamide for Injection Market by Company

Chongqing Yaoyou Pharmaceutical

Jiuquan Dadeli pharmaceutical

Jiangsu Jiuxu Pharmaceutical

North China Pharmaceutical Group

Hebei Zhitong Biopharmaceutical

Hainan Star Pharmaceutical

Haerbin Medisan

Cobamamide for Injection Segment by Type

0.5mg

1.5mg

1.0mg

Cobamamide for Injection Segment by Application

Hospital

Drug Store

Other

Cobamamide for Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobamamide for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cobamamide for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobamamide for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cobamamide for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cobamamide for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.5mg Table 2. Major Company of 1.5mg Table 3. Major Company of 1.0mg Table 4. Global Cobamamide for Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cobamamide for Injection Sales by Type (2021-2026) & (Kg) Table 6. Global Cobamamide for Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cobamamide for Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cobamamide for Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Cobamamide for Injection Price by Type (2021-2026) & (US$/g) Table 10. Global Cobamamide for Injection Sales by Type (2027-2032) & (Kg) Table 11. Global Cobamamide for Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cobamamide for Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cobamamide for Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Cobamamide for Injection Price by Type (2027-2032) & (US$/g) Table 15. North America Cobamamide for Injection Sales by Type (2021-2026) & (Kg) Table 16. North America Cobamamide for Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cobamamide for Injection Sales by Type (2021-2026) & (Kg) Table 18. Europe Cobamamide for Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cobamamide for Injection Sales by Type (2021-2026) & (Kg) Table 20. Asia-Pacific Cobamamide for Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cobamamide for Injection Sales by Type (2021-2026) & (Kg) Table 22. Latin America Cobamamide for Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cobamamide for Injection Sales by Type (2021-2026) & (Kg) Table 24. Middle East and Africa Cobamamide for Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Cobamamide for Injection Industry Trends Table 26. Cobamamide for Injection Industry Drivers Table 27. Cobamamide for Injection Industry Opportunities and Challenges Table 28. Cobamamide for Injection Industry Restraints Table 29. Global Cobamamide for Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cobamamide for Injection Revenue Market Share by Company (2021-2026) Table 31. Global Cobamamide for Injection Sales by Company (2021-2026) & (Kg) Table 32. Global Cobamamide for Injection Sales Share by Company (2021-2026) Table 33. Global Cobamamide for Injection Market Price by Company (2021-2026) & (US$/g) Table 34. Global Cobamamide for Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cobamamide for Injection Major Company Production Sites and Headquarters Table 36. Global Cobamamide for Injection Company, Product Type & Application Table 37. Global Cobamamide for Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cobamamide for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cobamamide for Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cobamamide for Injection Sales by Region (2021-2026) & (Kg) Table 42. Global Cobamamide for Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cobamamide for Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cobamamide for Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Cobamamide for Injection Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 46. Global Cobamamide for Injection Sales by Region (2027-2032) & (Kg) Table 47. Global Cobamamide for Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cobamamide for Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cobamamide for Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Cobamamide for Injection Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 51. Global Cobamamide for Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cobamamide for Injection Sales by Application (2021-2026) & (Kg) Table 53. Global Cobamamide for Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cobamamide for Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cobamamide for Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Cobamamide for Injection Price by Application (2021-2026) & (US$/g) Table 57. Global Cobamamide for Injection Sales by Application (2027-2032) & (Kg) Table 58. Global Cobamamide for Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cobamamide for Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cobamamide for Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Cobamamide for Injection Price by Application (2027-2032) & (US$/g) Table 62. North America Cobamamide for Injection Sales by Application (2021-2026) & (Kg) Table 63. North America Cobamamide for Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cobamamide for Injection Sales by Application (2021-2026) & (Kg) Table 65. Europe Cobamamide for Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cobamamide for Injection Sales by Application (2021-2026) & (Kg) Table 67. Asia-Pacific Cobamamide for Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cobamamide for Injection Sales by Application (2021-2026) & (Kg) Table 69. Latin America Cobamamide for Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cobamamide for Injection Sales by Application (2021-2026) & (Kg) Table 71. Middle East and Africa Cobamamide for Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Chongqing Yaoyou Pharmaceutical Company Information Table 73. Chongqing Yaoyou Pharmaceutical Business Overview Table 74. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 75. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Portfolio Table 76. Chongqing Yaoyou Pharmaceutical Recent Development Table 77. Jiuquan Dadeli pharmaceutical Company Information Table 78. Jiuquan Dadeli pharmaceutical Business Overview Table 79. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 80. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Portfolio Table 81. Jiuquan Dadeli pharmaceutical Recent Development Table 82. Jiangsu Jiuxu Pharmaceutical Company Information Table 83. Jiangsu Jiuxu Pharmaceutical Business Overview Table 84. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 85. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Portfolio Table 86. Jiangsu Jiuxu Pharmaceutical Recent Development Table 87. North China Pharmaceutical Group Company Information Table 88. North China Pharmaceutical Group Business Overview Table 89. North China Pharmaceutical Group Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 90. North China Pharmaceutical Group Cobamamide for Injection Product Portfolio Table 91. North China Pharmaceutical Group Recent Development Table 92. Hebei Zhitong Biopharmaceutical Company Information Table 93. Hebei Zhitong Biopharmaceutical Business Overview Table 94. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 95. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Portfolio Table 96. Hebei Zhitong Biopharmaceutical Recent Development Table 97. Hainan Star Pharmaceutical Company Information Table 98. Hainan Star Pharmaceutical Business Overview Table 99. Hainan Star Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 100. Hainan Star Pharmaceutical Cobamamide for Injection Product Portfolio Table 101. Hainan Star Pharmaceutical Recent Development Table 102. Haerbin Medisan Company Information Table 103. Haerbin Medisan Business Overview Table 104. Haerbin Medisan Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 105. Haerbin Medisan Cobamamide for Injection Product Portfolio Table 106. Haerbin Medisan Recent Development Table 107. North America Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 108. North America Cobamamide for Injection Sales by Country (2021-2026) & (Kg) Table 109. North America Cobamamide for Injection Sales Market Share by Country (2021-2026) Table 110. North America Cobamamide for Injection Sales Forecast by Country (2027-2032) & (Kg) Table 111. North America Cobamamide for Injection Sales Market Share Forecast by Country (2027-2032) Table 112. North America Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Cobamamide for Injection Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Cobamamide for Injection Market Share by Country (2021-2026) Table 115. North America Cobamamide for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Cobamamide for Injection Market Share Forecast by Country (2027-2032) Table 117. Europe Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 118. Europe Cobamamide for Injection Sales by Country (2021-2026) & (Kg) Table 119. Europe Cobamamide for Injection Sales Market Share by Country (2021-2026) Table 120. Europe Cobamamide for Injection Sales Forecast by Country (2027-2032) & (Kg) Table 121. Europe Cobamamide for Injection Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Cobamamide for Injection Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Cobamamide for Injection Market Share by Country (2021-2026) Table 125. Europe Cobamamide for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Cobamamide for Injection Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Cobamamide for Injection Sales by Country (2021-2026) & (Kg) Table 129. Asia-Pacific Cobamamide for Injection Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Cobamamide for Injection Sales Forecast by Country (2027-2032) & (Kg) Table 131. Asia-Pacific Cobamamide for Injection Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Cobamamide for Injection Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Cobamamide for Injection Market Share by Country (2021-2026) Table 135. Asia-Pacific Cobamamide for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Cobamamide for Injection Market Share Forecast by Country (2027-2032) Table 137. Latin America Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 138. Latin America Cobamamide for Injection Sales by Country (2021-2026) & (Kg) Table 139. Latin America Cobamamide for Injection Sales Market Share by Country (2021-2026) Table 140. Latin America Cobamamide for Injection Sales Forecast by Country (2027-2032) & (Kg) Table 141. Latin America Cobamamide for Injection Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Cobamamide for Injection Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Cobamamide for Injection Market Share by Country (2021-2026) Table 145. Latin America Cobamamide for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Cobamamide for Injection Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Cobamamide for Injection Sales by Country (2021-2026) & (Kg) Table 149. Middle East and Africa Cobamamide for Injection Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Cobamamide for Injection Sales Forecast by Country (2027-2032) & (Kg) Table 151. Middle East and Africa Cobamamide for Injection Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Cobamamide for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Cobamamide for Injection Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Cobamamide for Injection Market Share by Country (2021-2026) Table 155. Middle East and Africa Cobamamide for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Cobamamide for Injection Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Cobamamide for Injection Distributors List Table 160. Cobamamide for Injection Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Cobamamide for Injection Image Figure 2. Global Cobamamide for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cobamamide for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cobamamide for Injection Sales (2021-2032) & (Kg) Figure 5. 0.5mg Image Figure 6. Global 0.5mg Sales YoY Growth (2021-2032) & (Kg) Figure 7. 1.5mg Image Figure 8. Global 1.5mg Sales YoY Growth (2021-2032) & (Kg) Figure 9. 1.0mg Image Figure 10. Global 1.0mg Sales YoY Growth (2021-2032) & (Kg) Figure 11. Global Cobamamide for Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cobamamide for Injection Market Share by Type 2025 VS 2032 Figure 13. North America Cobamamide for Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Cobamamide for Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Cobamamide for Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cobamamide for Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cobamamide for Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cobamamide for Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cobamamide for Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cobamamide for Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cobamamide for Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cobamamide for Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cobamamide for Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (Kg) Figure 27. Drug Store Image Figure 28. Global Drug Store Sales YoY Growth (2021-2032) & (Kg) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Cobamamide for Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cobamamide for Injection Market Share by Application 2025 VS 2032 Figure 33. North America Cobamamide for Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Cobamamide for Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Cobamamide for Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cobamamide for Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cobamamide for Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cobamamide for Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cobamamide for Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cobamamide for Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cobamamide for Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cobamamide for Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Cobamamide for Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Cobamamide for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cobamamide for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cobamamide for Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Cobamamide for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cobamamide for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cobamamide for Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Cobamamide for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cobamamide for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cobamamide for Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Cobamamide for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cobamamide for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cobamamide for Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Cobamamide for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cobamamide for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cobamamide for Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cobamamide for Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5mg
  • 1.5mg
  • 1.0mg
Applications
  • Hospital
  • Drug Store
  • Other
Companies covered
  • Chongqing Yaoyou Pharmaceutical
  • Jiuquan Dadeli pharmaceutical
  • Jiangsu Jiuxu Pharmaceutical
  • North China Pharmaceutical Group
  • Hebei Zhitong Biopharmaceutical
  • Hainan Star Pharmaceutical
  • Haerbin Medisan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cobamamide for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cobamamide for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cobamamide for Injection Market by Type
  6. 1.3.1 0.5mg
  7. 1.3.2 1.5mg
  8. 1.3.3 1.0mg
  9. 1.4 Global Cobamamide for Injection Market Size by Type
  10. 1.4.1 Global Cobamamide for Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cobamamide for Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cobamamide for Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cobamamide for Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cobamamide for Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cobamamide for Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cobamamide for Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cobamamide for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cobamamide for Injection Industry Trends
  2. 2.2 Cobamamide for Injection Industry Drivers
  3. 2.3 Cobamamide for Injection Industry Opportunities and Challenges
  4. 2.4 Cobamamide for Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cobamamide for Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Cobamamide for Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Cobamamide for Injection Price (2021-2026)
  4. 3.4 Global Cobamamide for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cobamamide for Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Cobamamide for Injection Company, Product Type & Application
  7. 3.7 Global Cobamamide for Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cobamamide for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cobamamide for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cobamamide for Injection Tier 1, Tier 2, and Tier 3
4 Cobamamide for Injection Regional Status and Outlook
  1. 4.1 Global Cobamamide for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cobamamide for Injection Historic Market Size by Region
  3. 4.2.1 Global Cobamamide for Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cobamamide for Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cobamamide for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cobamamide for Injection Forecasted Market Size by Region
  7. 4.3.1 Global Cobamamide for Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cobamamide for Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cobamamide for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cobamamide for Injection by Application
  1. 5.1 Cobamamide for Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.1.3 Other
  5. 5.2 Global Cobamamide for Injection Market Size by Application
  6. 5.2.1 Global Cobamamide for Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cobamamide for Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cobamamide for Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cobamamide for Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cobamamide for Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cobamamide for Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cobamamide for Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cobamamide for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Yaoyou Pharmaceutical
  2. 6.1.1 Chongqing Yaoyou Pharmaceutical Company Information
  3. 6.1.2 Chongqing Yaoyou Pharmaceutical Business Overview
  4. 6.1.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Portfolio
  6. 6.1.5 Chongqing Yaoyou Pharmaceutical Recent Developments
  7. 6.2 Jiuquan Dadeli pharmaceutical
  8. 6.2.1 Jiuquan Dadeli pharmaceutical Company Information
  9. 6.2.2 Jiuquan Dadeli pharmaceutical Business Overview
  10. 6.2.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Portfolio
  12. 6.2.5 Jiuquan Dadeli pharmaceutical Recent Developments
  13. 6.3 Jiangsu Jiuxu Pharmaceutical
  14. 6.3.1 Jiangsu Jiuxu Pharmaceutical Company Information
  15. 6.3.2 Jiangsu Jiuxu Pharmaceutical Business Overview
  16. 6.3.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Portfolio
  18. 6.3.5 Jiangsu Jiuxu Pharmaceutical Recent Developments
  19. 6.4 North China Pharmaceutical Group
  20. 6.4.1 North China Pharmaceutical Group Company Information
  21. 6.4.2 North China Pharmaceutical Group Business Overview
  22. 6.4.3 North China Pharmaceutical Group Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 North China Pharmaceutical Group Cobamamide for Injection Product Portfolio
  24. 6.4.5 North China Pharmaceutical Group Recent Developments
  25. 6.5 Hebei Zhitong Biopharmaceutical
  26. 6.5.1 Hebei Zhitong Biopharmaceutical Company Information
  27. 6.5.2 Hebei Zhitong Biopharmaceutical Business Overview
  28. 6.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Portfolio
  30. 6.5.5 Hebei Zhitong Biopharmaceutical Recent Developments
  31. 6.6 Hainan Star Pharmaceutical
  32. 6.6.1 Hainan Star Pharmaceutical Company Information
  33. 6.6.2 Hainan Star Pharmaceutical Business Overview
  34. 6.6.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hainan Star Pharmaceutical Cobamamide for Injection Product Portfolio
  36. 6.6.5 Hainan Star Pharmaceutical Recent Developments
  37. 6.7 Haerbin Medisan
  38. 6.7.1 Haerbin Medisan Company Information
  39. 6.7.2 Haerbin Medisan Business Overview
  40. 6.7.3 Haerbin Medisan Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Haerbin Medisan Cobamamide for Injection Product Portfolio
  42. 6.7.5 Haerbin Medisan Recent Developments
7 North America by Country
  1. 7.1 North America Cobamamide for Injection Sales by Country
  2. 7.1.1 North America Cobamamide for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cobamamide for Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Cobamamide for Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cobamamide for Injection Market Size by Country
  6. 7.2.1 North America Cobamamide for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cobamamide for Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Cobamamide for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cobamamide for Injection Sales by Country
  2. 8.1.1 Europe Cobamamide for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cobamamide for Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Cobamamide for Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cobamamide for Injection Market Size by Country
  6. 8.2.1 Europe Cobamamide for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cobamamide for Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cobamamide for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cobamamide for Injection Sales by Country
  2. 9.1.1 Asia-Pacific Cobamamide for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cobamamide for Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cobamamide for Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cobamamide for Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Cobamamide for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cobamamide for Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cobamamide for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cobamamide for Injection Sales by Country
  2. 10.1.1 South America Cobamamide for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cobamamide for Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Cobamamide for Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cobamamide for Injection Market Size by Country
  6. 10.2.1 South America Cobamamide for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cobamamide for Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Cobamamide for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cobamamide for Injection Sales by Country
  2. 11.1.1 Middle East and Africa Cobamamide for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cobamamide for Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cobamamide for Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cobamamide for Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Cobamamide for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cobamamide for Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cobamamide for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cobamamide for Injection Value Chain Analysis
  2. 12.1.1 Cobamamide for Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cobamamide for Injection Production Mode & Process
  7. 12.2 Cobamamide for Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cobamamide for Injection Distributors
  10. 12.2.3 Cobamamide for Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst